Comorbidity and its prognostic significance in patients with myocardial infarction myocardium

MI is still an urgent medical and social problem. Due to the high socio-economic significance of this nosology, there is an increasing interest in studying the etiology, pathogenesis and clinical features of MI in young and middle-aged people. Despite a sufficient amount of literature data characterizing the etiopathogenesis of MI in general, the question of the significance of certain traditional risk factors in the formation of MI in young and middle-aged patients remains open. Currently, there are practically no studies devoted to the study of the structure and prognostic significance of comorbid conditions in this category of patients. There is a need to create original statistical models of risk stratification in young and middle-aged MI patients using "new" genetic and biochemical markers. However, the possibility of combining humoral and clinical-genetic markers to predict and stratify the risk of MI in young and middle-aged patients requires further study and is of independent practical importance for the development of effective programs for primary and secondary prevention of MI in this category of patients. One of the effective ways to obtain this kind of information is the creation of independent registries of patients who have had MI.